KAPOSI’S SARCOMA IN PEOPLE LIVING WITH HIV/AIDS IN A PUBLIC REFERRAL HOSPITAL IN PERU

Mori L.M.M.; Medina J.B.V.; Herencia J.E.G.; Puccio F.G.B.; Cordero F.A.M.; Barrenechea S.M.; Lagos E.V.G. · Revista Peruana de Medicina Experimental y Salud Publica (2022) · DOI: 10.17843/rpmesp.2022.393.10883

Resumen

Kaposi’s sarcoma (KS) is the most frequent cancer in people living with HIV. Research on this condition is scarce in the region, therefore, this article aimed to describe the demographic, clinical and therapeutic characteristics of patients with HIV who developed KS at the Cayetano Heredia Hospital between 2000 and 2018. A total of 129 KS cases were identified, with a median age of 33 years, predominantly males with 92% (119/129), and mostly men who have sex with men (MSM). The median time from HIV diagnosis to KS diagnosis was five months, associated with a CD4 lymphocyte count of 64 cells/μL (IQR: 33-185) at KS diagnosis. Cutaneous involvement was the most common presentation; however, at least half also had the visceral form.

Instituciones: Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos